HK1169656A1 - Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines n--1-(4-)-1h--3- - Google Patents
Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines n--1-(4-)-1h--3-Info
- Publication number
- HK1169656A1 HK1169656A1 HK12110507.1A HK12110507A HK1169656A1 HK 1169656 A1 HK1169656 A1 HK 1169656A1 HK 12110507 A HK12110507 A HK 12110507A HK 1169656 A1 HK1169656 A1 HK 1169656A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pyrazol
- pyridinyl
- amines
- phenyl
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09170525 | 2009-09-17 | ||
| PCT/EP2010/063609 WO2011033018A1 (fr) | 2009-09-17 | 2010-09-16 | N-phényl-1-(4-pyridinyl)-1h-pyrazol-3-amines substituées |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1169656A1 true HK1169656A1 (en) | 2013-02-01 |
Family
ID=41466623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK12110507.1A HK1169656A1 (en) | 2009-09-17 | 2012-10-22 | Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines n--1-(4-)-1h--3- |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8791144B2 (fr) |
| EP (1) | EP2491024B1 (fr) |
| JP (1) | JP5636428B2 (fr) |
| KR (1) | KR101710197B1 (fr) |
| CN (1) | CN102574832B (fr) |
| AU (1) | AU2010297263B2 (fr) |
| BR (1) | BR112012005960A2 (fr) |
| CA (1) | CA2770932C (fr) |
| EA (1) | EA020564B1 (fr) |
| ES (1) | ES2446356T3 (fr) |
| HK (1) | HK1169656A1 (fr) |
| WO (1) | WO2011033018A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| JO2784B1 (en) * | 2007-10-18 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | 5,3,1 - Triazole substitute derivative |
| CA2697974C (fr) * | 2007-10-18 | 2015-06-30 | Janssen Pharmaceutica Nv | 1,2,4-triazoles trisubstitues |
| KR101564303B1 (ko) * | 2008-03-19 | 2015-11-06 | 얀센 파마슈티카 엔.브이. | 니코틴성 아세틸콜린 수용체 조절제로서의 삼치환된 1,2,4-트리아졸 |
| WO2009135944A1 (fr) * | 2008-05-09 | 2009-11-12 | Janssen Pharmaceutica Nv | Pyrazoles trisubstitués en tant que modulateurs des récepteurs de l'acétylcholine |
| PL3029039T3 (pl) | 2010-05-17 | 2018-04-30 | Forum Pharmaceuticals Inc. | Formulacje farmaceutyczne zawierające postacie krystaliczne jednowodnego chlorowodorku (R)-7-chloro-N-(chinuklidyn-3-ylo)benzo[b]tiofeno-2-karboksyamidu |
| DE102011055815A1 (de) | 2011-11-29 | 2013-05-29 | Aicuris Gmbh & Co. Kg | Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung |
| AU2013259871A1 (en) | 2012-05-08 | 2014-11-20 | Forum Pharmaceuticals Inc. | Methods of maintaining, treating or improving cognitive function |
| DE102012016908A1 (de) | 2012-08-17 | 2014-02-20 | Aicuris Gmbh & Co. Kg | Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung |
| CN109790150A (zh) | 2016-08-11 | 2019-05-21 | 拜耳作物科学股份公司 | 取代的吡唑啉基衍生物、其制备方法及其作为除草剂和/或植物生长调节剂的用途 |
| WO2019000236A1 (fr) | 2017-06-27 | 2019-01-03 | Merck Sharp & Dohme Corp. | Modulateurs allostériques de 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine |
| WO2021078810A1 (fr) * | 2019-10-21 | 2021-04-29 | Cambridge Cognition Ltd. | Traitement d'un trouble schizophrénique par polythérapie |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0248523B1 (fr) | 1986-05-07 | 1991-10-16 | FISONS plc | Pyrazoles |
| FR2862647B1 (fr) * | 2003-11-25 | 2008-07-04 | Aventis Pharma Sa | Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant |
| WO2006064375A2 (fr) * | 2004-12-16 | 2006-06-22 | Ab Science | Composes heterocycliques a noyau a cinq elements a substitution aminoaryle pour le traitement de maladies |
| EA015034B1 (ru) * | 2005-09-13 | 2011-04-29 | Янссен Фармацевтика Н.В. | 2-анилин-4-арилзамещенные тиазольные производные |
| JO3019B1 (ar) * | 2006-04-19 | 2016-09-05 | Janssen Pharmaceutica Nv | ثلاثي مستبدل 4،2،1-ثلاثي زولات |
| WO2009135944A1 (fr) | 2008-05-09 | 2009-11-12 | Janssen Pharmaceutica Nv | Pyrazoles trisubstitués en tant que modulateurs des récepteurs de l'acétylcholine |
-
2010
- 2010-09-16 CN CN201080042029.6A patent/CN102574832B/zh active Active
- 2010-09-16 JP JP2012529269A patent/JP5636428B2/ja active Active
- 2010-09-16 WO PCT/EP2010/063609 patent/WO2011033018A1/fr active Application Filing
- 2010-09-16 EP EP10757753.8A patent/EP2491024B1/fr active Active
- 2010-09-16 KR KR1020127006155A patent/KR101710197B1/ko active IP Right Grant
- 2010-09-16 ES ES10757753.8T patent/ES2446356T3/es active Active
- 2010-09-16 US US13/496,120 patent/US8791144B2/en active Active
- 2010-09-16 BR BR112012005960A patent/BR112012005960A2/pt not_active Application Discontinuation
- 2010-09-16 CA CA2770932A patent/CA2770932C/fr active Active
- 2010-09-16 AU AU2010297263A patent/AU2010297263B2/en not_active Ceased
- 2010-09-16 EA EA201270428A patent/EA020564B1/ru not_active IP Right Cessation
-
2012
- 2012-10-22 HK HK12110507.1A patent/HK1169656A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EA201270428A1 (ru) | 2012-08-30 |
| EP2491024A1 (fr) | 2012-08-29 |
| US20120172354A1 (en) | 2012-07-05 |
| JP2013505217A (ja) | 2013-02-14 |
| CN102574832B (zh) | 2014-09-24 |
| CA2770932A1 (fr) | 2011-03-24 |
| CA2770932C (fr) | 2017-04-25 |
| ES2446356T3 (es) | 2014-03-07 |
| EA020564B1 (ru) | 2014-12-30 |
| BR112012005960A2 (pt) | 2016-03-15 |
| EP2491024B1 (fr) | 2013-11-20 |
| WO2011033018A1 (fr) | 2011-03-24 |
| US8791144B2 (en) | 2014-07-29 |
| AU2010297263B2 (en) | 2014-07-10 |
| KR20120089805A (ko) | 2012-08-13 |
| JP5636428B2 (ja) | 2014-12-03 |
| KR101710197B1 (ko) | 2017-02-24 |
| CN102574832A (zh) | 2012-07-11 |
| AU2010297263A1 (en) | 2012-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3023438T3 (en) | Anti-gitr-antistoffer | |
| HK1168791A1 (en) | Substituted imidazoquinoxalines | |
| EP2412708A4 (fr) | Dérivé de 3-hydroxy-4-pyridone substitué | |
| EP2514747A4 (fr) | Dérivé d'aminothiazine substitué | |
| ZA201105479B (en) | Pyridine derivative | |
| EP2457176A4 (fr) | Fourniture de service d'application à base de machines virtuelles | |
| EP2462514A4 (fr) | Livre vert | |
| EP2515891A4 (fr) | 3-céto-n-propargyl-1-aminoindane | |
| HK1169656A1 (en) | Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines n--1-(4-)-1h--3- | |
| HK1176606A1 (en) | 2-pyridone compounds 2- | |
| PL2464939T3 (pl) | Udoskonalony nośnik przedmiotu obrabianego | |
| HK1174617A1 (en) | Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts -1----2--- | |
| EP2456311A4 (fr) | Imidasotriazines substituées | |
| GB0914596D0 (en) | Improved hatchcover | |
| IL213466A0 (en) | Spiroindolinone pyridine derivative | |
| EP2519921A4 (fr) | Traçage d'appels | |
| ZA201108565B (en) | Substituted piperidnes | |
| DK2464943T3 (en) | Systemintegration | |
| EP2448583A4 (fr) | 4-hydroxypyrimidine-5-carboxamides substitués | |
| EP2448584A4 (fr) | 4-hydroxypyrimidine-5-carboxamides substitués | |
| GB0900319D0 (en) | Hydrocharger | |
| EP2510125A4 (fr) | Hyperamorces | |
| EP2424860A4 (fr) | Dérivé d'hétéroarylthiométhyl pyridine | |
| AU4924P (en) | Bonscablue Scaevola aemula | |
| AU4925P (en) | Bonscawi Scaevola aemula |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230920 |